NetworkNewsBreaks – Lexaria Bioscience Corp. (CS
Post# of 721
Biotechnology company and drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) today announced its entry into a definitive 5-year agreement, via its subsidiary Lexaria Hemp Corp, with Nic’s Beverages L.L.C. Under the agreement, Lexaria will provide its patented DehydraTECH(TM) technology for use in Nic’s CBD-based beverages to be produced and sold throughout the United States. According to the update, Nic’s Beverages will initially begin production of ready-to-drink cold brew coffees enhanced with CBD from multi spectrum hemp oil. “We are currently in discussions with major wholesale houses and are looking to be in the market by the first of October,” Nic’s Beverages CEO John Goodpasture said in the news release. “DehydraTECH technology is perfect in allowing us to deliver CBD from hemp oil with zero impact on our cold brewed coffee’s outstanding aroma or flavour. Nic’s is extremely excited about our new product lines and our continued growth with Lexaria.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer